← Back to headlines
Piper Sandler Maintains Overweight Rating for Boston Scientific
Piper Sandler has reiterated its 'Overweight' rating for Boston Scientific (BSX), signaling continued confidence in the medical technology company's stock.
23 Jun, 15:06 — 23 Jun, 15:06
Sources
Showing 1 of 1 sources
